Many patients with inflammatory bowel disease (IBD) suffer from disease-associated symptoms outside the gastrointestinal tract. Classic extraintestinal manifestations (EIM) that may occur in association with IBD include rheumatologic, ocular, cutaneous, and hepatobiliary symptoms. The most common EIM are rheumatologic conditions (peripheral arthritis, spondyloarthritis). Anemia is one of the most common comorbidities in patients with IBD. Therefore, this should also be clarified during follow-up and, if necessary, treated by means of iron substitution therapy.
Manifestations outside the gatrointestinal tract can additionally have a massive impact on the quality of life of IBD patients. Multidisciplinary collaboration is essential for effective treatment. The treatment spectrum available today ranges from conventional drugs to state-of-the-art biologics and JAK inhibitors. Read the second article in the “IBD matters” series for a comprehensive overview of the extraintestinal manifestations of inflammatory bowel disease (IBD).
This contribution is supported by
